Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Peter Impey

- PMLiVE

Passion for science leads to promotion at Porterhouse Medical

It is with enormous pleasure that Porterhouse Medical announces the promotion of Rebecca Thomas to account manager.   Becky has a passion for science and gained a biological sciences degree from the...

Porterhouse Medical Group

- PMLiVE

Irritable Bowel Syndrome (IBS) patient insights

It’s common. It’s debilitating. We’re talking about IBS. In this issue of MAGNIFI, we explore the insights of patients suffering with IBS, while also looking into research around the HCP–patient...

IGNIFI

- PMLiVE

New appointment in Porterhouse Medical’s scientific services team.

Porterhouse Medical is delighted to welcome Devdutt Sharma to our scientific services team as associate medical writer. Dev has more than 5 years of scientific experience in an academic environment...

Porterhouse Medical Group

Regeneron and Bluebird sign $100m cell therapies deal

Six targets chosen from TCR and other cell therapy platforms

- PMLiVE

Almirall acquires Allergan’s dermatology portfolio for $650m

The pharma group buys four products along with Allergan's first-in-class antibiotic Seysara

- PMLiVE

Boehringer and partners set sights on cystic fibrosis gene therapy

Deal builds on 17 years work in UK academic consortium

- PMLiVE

How pharma can unlock the potential of influencer marketing

Building a successful campaign around influencer marketing

- PMLiVE

Cancer immunotherapy: What’s on the horizon?

Old and new therapies

- PMLiVE

Ionis and Roche gain PRIME status for Huntingdon’s disease candidate

More good news for Ionis after first drug approval

- PMLiVE

Daily Brief: Cellectis gains Novartis scientist, EU label updates for Janssen and Otsuka

The latest from pharma, biotech and healthcare

- PMLiVE

Mallinckrodt doses first patient in muscular dystrophy trial

Repurposed drug could help delay decline in muscle function

- PMLiVE

China’s BeiGene raises $903m from Hong Kong IPO

Mammoth debut might have exceeded $1bn but for market jitters

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links